KR910004648A - 유기산과 19-노르 스테로이드의 알코올 유도체와의 신규에스테르 및 이들의 염, 이들의 제조방법 및 이 방법의 중간체, 의약품으로서 이들의 용도 및 이들을 함유한 조성물 - Google Patents

유기산과 19-노르 스테로이드의 알코올 유도체와의 신규에스테르 및 이들의 염, 이들의 제조방법 및 이 방법의 중간체, 의약품으로서 이들의 용도 및 이들을 함유한 조성물 Download PDF

Info

Publication number
KR910004648A
KR910004648A KR1019900012166A KR900012166A KR910004648A KR 910004648 A KR910004648 A KR 910004648A KR 1019900012166 A KR1019900012166 A KR 1019900012166A KR 900012166 A KR900012166 A KR 900012166A KR 910004648 A KR910004648 A KR 910004648A
Authority
KR
South Korea
Prior art keywords
group
compound
formula
carbon atoms
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1019900012166A
Other languages
English (en)
Korean (ko)
Inventor
모킬레위스키 마르틴느
네델레 루시엥
니끄 프랑스와
필리베르 다니엘
Original Assignee
로우셀-우크라프
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로우셀-우크라프 filed Critical 로우셀-우크라프
Publication of KR910004648A publication Critical patent/KR910004648A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019900012166A 1989-08-08 1990-08-07 유기산과 19-노르 스테로이드의 알코올 유도체와의 신규에스테르 및 이들의 염, 이들의 제조방법 및 이 방법의 중간체, 의약품으로서 이들의 용도 및 이들을 함유한 조성물 Abandoned KR910004648A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8910648A FR2650748B1 (fr) 1989-08-08 1989-08-08 Nouveaux esters d'acides organiques avec des alcools derives de 19-nor steroides et leurs sels, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions les renfermant
FR10648/89 1989-08-08

Publications (1)

Publication Number Publication Date
KR910004648A true KR910004648A (ko) 1991-03-29

Family

ID=9384560

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900012166A Abandoned KR910004648A (ko) 1989-08-08 1990-08-07 유기산과 19-노르 스테로이드의 알코올 유도체와의 신규에스테르 및 이들의 염, 이들의 제조방법 및 이 방법의 중간체, 의약품으로서 이들의 용도 및 이들을 함유한 조성물

Country Status (27)

Country Link
EP (1) EP0412907B1 (enExample)
JP (1) JP3056770B2 (enExample)
KR (1) KR910004648A (enExample)
CN (1) CN1036521C (enExample)
AT (1) ATE113958T1 (enExample)
AU (1) AU633604B2 (enExample)
CA (1) CA2022647A1 (enExample)
DE (1) DE69014012T2 (enExample)
DK (1) DK0412907T3 (enExample)
EG (1) EG19423A (enExample)
ES (1) ES2063940T3 (enExample)
FI (1) FI903905A7 (enExample)
FR (1) FR2650748B1 (enExample)
HU (1) HUT55031A (enExample)
IE (1) IE65905B1 (enExample)
IL (1) IL95272A (enExample)
MA (1) MA21925A1 (enExample)
MX (1) MX21771A (enExample)
NO (1) NO177595C (enExample)
NZ (1) NZ234824A (enExample)
OA (1) OA09303A (enExample)
PT (1) PT94935B (enExample)
RU (1) RU2056431C1 (enExample)
TN (1) TNSN90112A1 (enExample)
TW (1) TW201313B (enExample)
YU (1) YU47865B (enExample)
ZA (1) ZA905812B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102518275B1 (ko) * 2022-07-27 2023-04-05 주식회사 화성케미칼 재생 네오프렌 원단의 합포 방법

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2659233B1 (fr) * 1990-03-06 1994-01-21 Roussel Uclaf Nouvelle utilisation de composes anti-progestomimetiques chez les animaux d'elevage.
DE4434488A1 (de) * 1994-09-14 1996-03-21 Schering Ag Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
AUPN058895A0 (en) * 1995-01-16 1995-02-09 Garvan Institute Of Medical Research Diagnostic method
US6090798A (en) * 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
DE19915871A1 (de) 1998-04-09 1999-10-21 Unisia Jecs Corp Viskosefluidkupplung
JP2000130165A (ja) 1998-10-30 2000-05-09 Unisia Jecs Corp ファンカップリング装置
JP2001012511A (ja) 1999-06-25 2001-01-16 Unisia Jecs Corp 流体継手
CN110099688A (zh) * 2016-11-17 2019-08-06 赛途公司 骨骼肌肥大诱导物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3506785A1 (de) * 1985-02-22 1986-08-28 Schering AG, Berlin und Bergkamen, 1000 Berlin 11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
ATE85342T1 (de) * 1987-12-12 1993-02-15 Akzo Nv 11-arylsteroid-derivate.
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102518275B1 (ko) * 2022-07-27 2023-04-05 주식회사 화성케미칼 재생 네오프렌 원단의 합포 방법

Also Published As

Publication number Publication date
ZA905812B (en) 1991-09-25
HUT55031A (en) 1991-04-29
FI903905A7 (fi) 1991-02-09
NZ234824A (en) 1993-03-26
PT94935A (pt) 1991-04-18
NO903475D0 (no) 1990-08-07
CN1049352A (zh) 1991-02-20
EP0412907A3 (en) 1991-07-24
NO177595C (no) 1995-10-18
MA21925A1 (fr) 1991-04-01
CA2022647A1 (fr) 1991-02-09
YU47865B (sh) 1996-02-19
CN1036521C (zh) 1997-11-26
NO177595B (no) 1995-07-10
TW201313B (enExample) 1993-03-01
TNSN90112A1 (fr) 1991-03-05
FR2650748B1 (fr) 1991-11-08
EP0412907A2 (fr) 1991-02-13
OA09303A (fr) 1992-09-15
AU633604B2 (en) 1993-02-04
MX21771A (es) 1993-10-01
NO903475L (no) 1991-04-11
IE902839A1 (en) 1991-02-27
HU904921D0 (en) 1991-01-28
FI903905A0 (fi) 1990-08-07
YU151390A (sh) 1992-12-21
IL95272A0 (en) 1991-06-30
FR2650748A1 (fr) 1991-02-15
RU2056431C1 (ru) 1996-03-20
DE69014012D1 (de) 1994-12-15
AU6020890A (en) 1991-02-14
DK0412907T3 (da) 1995-04-03
JPH0377825A (ja) 1991-04-03
JP3056770B2 (ja) 2000-06-26
DE69014012T2 (de) 1995-03-30
EG19423A (en) 1995-02-28
PT94935B (pt) 1997-05-28
ATE113958T1 (de) 1994-11-15
ES2063940T3 (es) 1995-01-16
EP0412907B1 (fr) 1994-11-09
IL95272A (en) 1996-01-31
IE65905B1 (en) 1995-11-29

Similar Documents

Publication Publication Date Title
KR910004648A (ko) 유기산과 19-노르 스테로이드의 알코올 유도체와의 신규에스테르 및 이들의 염, 이들의 제조방법 및 이 방법의 중간체, 의약품으로서 이들의 용도 및 이들을 함유한 조성물
KR840007596A (ko) 유기인 유도체의염의 제조방법
KR890005086A (ko) 1-[(2- 피리미디닐) 아미노알킬]피페리딘, 그의 제법 및 치료에의 이용
KR890016009A (ko) 1,2,5,6-테트라히드로 피리딘유도체, 이들의 제조방법, 의약으로서 이들의 용도 및 이들을 함유하는 조성물
SE433748B (sv) Forfarande for framstellning av estrar av (6r, 7r-3-karbamoyloximetyl-7-((z)-2-(fur-2-yl)-2-metoxiimionacetamido)-cef-3-em-4-karbonsyra
JPH02149577A (ja) トコフェロール　アミノアルキルカルボン酸エステルおよびその塩
US4183924A (en) 17α-Chloro-17β-hydrocarbonsulfinyl-1,4-androstadienes and the corresponding 17β-hydrocarbonsulfonyl derivatives and their use as anti-acne agents
KR830006183A (ko) 카르니틴의 알콕시-아실 유도체의 에스테르 제조방법
ATE3028T1 (de) Cyclopentenon- und cyclopentenol-derivate und verfahren zu ihrer herstellung.
SE446338B (sv) 2-hydroximetyl-pyrazin-4-oxid-derivat, forfarande for framstellning derav samt farmaceutisk komposition innehallande dessa derivat
YU158385A (en) Process for obtaining derivatives of 2-pyridine thioles
DK260881A (da) Bis- og mono-kvaternaere ammoniumderivater af 2beta, 16beta-diperidino-5alfa-androstaner fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende androstanforbindelserne
KR920700210A (ko) 신규 이미다졸 유도체, 그의 제법 및 그의 의약용도
ATE11912T1 (de) ((indol-3-yl)-3-amino-2-propionyloxy)-2essigs|urederivate, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
JPS6485954A (en) Novel cinnamamide derivative and medicine containing said derivative
Lopez et al. Dexamethasone 21-(. beta.-isothiocyanatoethyl) thio ether: a new affinity label for glucocorticoid receptors
KR970042563A (ko) 새로운 세팔로스포린 유도체 및 그 제조방법
SE453992B (sv) Sett att framstella 2-tiofen-ettiksyraderivat
KR850004759A (ko) 피롤로[3,2,1-hi]인돌 유도체, 그의 제법 및 그를 함유하는 의약조성물
HU210480B (en) Process for the preparation of acetic acid-(trifluoromethanesulfonic acid) mixed anhydride derivatives
JPS6259708B2 (enExample)
JPH0283372A (ja) シクロヘキシルイミダゾール誘導体
KR850004758A (ko) 피라졸로 피리딘 유도체의 제법
ATE113941T1 (de) Substituierte n-(phenyl-(thioxomethyl)>- morpholinderivate, verfahren zu ihrer herstellung, diese enthaltende zusammensetzung und ihre verwendung.
KR960000882A (ko) 신규한 피리돈 카르본산 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19900807

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19950805

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19900807

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19980422

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19980829

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee